Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma External Web Site Icon JAMA Oncology, September 5, 2019

Specific PHGKB|Cancer|PHGKB

Cancer

- Cancer PHGKB -

What's New

Last Posted: Sep 06, 2019

---

• Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma 
  JAMA Oncology, September 5, 2019
• Reproducible Findings in Systematic Reviews and Meta-analyses in Oncology Verify, Then Trust 
  JM Unger, JAMA Oncology, September 5, 2019
• Assessment of Deep Learning Using Nonimaging Information and Sequential Medical Records to Develop a Prediction Model for Nonmelanoma Skin Cancer. 
  Wang Hsiao-Han et al. JAMA dermatology 2019 Sep
• Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk. 
  Xu Xue et al. JAMA network open 2019 Sep (9) e199292
• Has Genomic Medicine Delivered in Cancer? 
  DJ Kerr, Medscape, August 2019
• What you need to know about ovarian cancer
  CDC, 2019
• Breast Cancer Chemoprevention—Can We Make a Case for Precision Medicine? 
  M Daly et al, JAMA Oncology, September 3, 2019
• CHIPing away at breast cancer 
  AS Sperling, JNCI, August 2019
• Medications to Reduce Breast Cancer Risk-Promise and Limitations 
  LE Pace et al, JAMA, September 3, 2019
• Potential impact of immunotherapy agents on cognitive function in cancer patients 
  F Joly et al, JNCI, August 2019
• Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR 
  S Ghorashian et al, Nature Medicine, September 2, 2019
• Medication Use to Reduce Risk of Breast Cancer- US Preventive Services Task Force Recommendation Statement 
  USPSTF Recommendation, JAMA, September 3, 2019
• More Treatment Options Emerging for Some Men with Metastatic Prostate Cancer 
  NCI, 2019
• Developing a digital intervention for cancer survivors: an evidence-, theory- and person-based approach 
  K Brabdbury et al, NPJ Digital Medicine, September 2, 2019
• Pathogenic Germline Variants in Patients With Metastatic Breast Cancer. 
  Stuttgen Kelsey et al. JAMA oncology 2019 Aug